EUVIMEDEUVIMED entdecken
Open Access

Difluoroboronated tetrazine probes for rapid bioorthogonal fluorescence activation, no-wash STED imaging, and triggered drug release

Xiaomei Zhu iD, Jie Zhang iD, Haoxing Geng, Kai Wang, Yue Li, Xiuxiu Yang, Heng Shi iD, Junjie Tai, Xueyuan Yan iD, Yunfang Yang iD, Hongyan Sun iD, Qing Zhu iD

Science Advances · 15.08.2025 · 11 (33)

DOI: 10.1126/sciadv.adw1098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 15.08.2025. Verfasst von Xiaomei Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Functional Structural Lipid Synthesis and Application, College of Biotechnology and Bioengineering, Zhejiang University of…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Drug Liberation, Optical Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A unique class of bioorthogonal fluorogenic probes, based on difluoroboronated tetrazine ( Tz-BFs ), has been developed. These probes are the smallest tetrazine-based fluorescent structures and exhibit a high fluorescence turn-on ratio (up to 582-fold) following the inverse electron-demand Diels-Alder reaction. By engineering π-conjugated systems and using push-pull groups, their fluorescence emission can be tuned across blue to yellow (440 to 570 nanometers). They offer no-wash fluorogenic behavior, excellent cell permeability, rapid reaction kinetics, and high photostability, ideal for real-time biomolecule tracking, suborganelle bioorthogonal imaging, and metabolic labeling. In addition, they enable stimulated emission depletion (STED) microscopy for subdiffraction resolution imaging and have click-to-release functionality for simultaneous fluorescence activation and therapeutic agent release, such as TCO ( trans -cyclooctene)–DOX (doxorubicin). These probes provide broad potential for advanced imaging and drug delivery applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesDrug LiberationOptical ImagingHumansDoxorubicinFluorescenceMicroscopy, Fluorescence

Substanzen

Fluorescent DyesDoxorubicin

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Functional Structural Lipid Synthesis and Application, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
  • Department of Chemistry and COSDAF (Centre of Super-Diamond and Advanced Films), City University of Hong Kong, Hong Kong 999077, China.
  • College of Chemical Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.

ORCID-Profile: Xiaomei Zhu, Jie Zhang, Heng Shi, Xueyuan Yan, Yunfang Yang, Hongyan Sun, Qing Zhu

Zitieren

APA

Zhu, X., Zhang, J., Geng, H., Wang, K., Li, Y., Yang, X., Shi, H., Tai, J., Yan, X., Yang, Y., Sun, H., & Zhu, Q. (2025). Difluoroboronated tetrazine probes for rapid bioorthogonal fluorescence activation, no-wash STED imaging, and triggered drug release. Science Advances, 11(33). https://doi.org/10.1126/sciadv.adw1098

Vancouver

Zhu X, Zhang J, Geng H, Wang K, Li Y, Yang X, et al. Difluoroboronated tetrazine probes for rapid bioorthogonal fluorescence activation, no-wash STED imaging, and triggered drug release. Science Advances. 2025;11(33). doi:10.1126/sciadv.adw1098

BibTeX
@article{Zhu2025,
  author = {Zhu, Xiaomei and Zhang, Jie and Geng, Haoxing and Wang, Kai and Li, Yue and Yang, Xiuxiu and Shi, Heng and Tai, Junjie and Yan, Xueyuan and Yang, Yunfang and Sun, Hongyan and Zhu, Qing},
  title = {Difluoroboronated tetrazine probes for rapid bioorthogonal fluorescence activation, no-wash STED imaging, and triggered drug release},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {33},
  doi = {10.1126/sciadv.adw1098}
}
Kostenlos starten →